Global PET Radiopharmaceuticals Market Growth 2025-2031
The global PET Radiopharmaceuticals market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?PET Radiopharmaceuticals Industry Forecast? looks at past sales and reviews total world PET Radiopharmaceuticals sales in 2024, providing a comprehensive analysis by region and market sector of projected PET Radiopharmaceuticals sales for 2025 through 2031. With PET Radiopharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PET Radiopharmaceuticals industry.
This Insight Report provides a comprehensive analysis of the global PET Radiopharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PET Radiopharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global PET Radiopharmaceuticals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PET Radiopharmaceuticals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PET Radiopharmaceuticals.
This report presents a comprehensive overview, market shares, and growth opportunities of PET Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global PET Radiopharmaceuticals market?
What factors are driving PET Radiopharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PET Radiopharmaceuticals market opportunities vary by end market size?
How does PET Radiopharmaceuticals break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LP Information, Inc. (LPI) ' newest research report, the ?PET Radiopharmaceuticals Industry Forecast? looks at past sales and reviews total world PET Radiopharmaceuticals sales in 2024, providing a comprehensive analysis by region and market sector of projected PET Radiopharmaceuticals sales for 2025 through 2031. With PET Radiopharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world PET Radiopharmaceuticals industry.
This Insight Report provides a comprehensive analysis of the global PET Radiopharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on PET Radiopharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global PET Radiopharmaceuticals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for PET Radiopharmaceuticals and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global PET Radiopharmaceuticals.
This report presents a comprehensive overview, market shares, and growth opportunities of PET Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- F-18
- Ru-82
- Others
- Oncology
- Cardiology
- Neurology
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Cardinal Health Inc. (U.S.)
- Mallinckrodt plc (Ireland)
- GE Healthcare (U.K.)
- Lantheus Medical Imaging, Inc. (U.S.)
- Bayer AG (Germany)
- Bracco Imaging S.p.A (Italy)
- Eczacibasi-Monrol Nuclear Products (Turkey)
- Nordion, Inc. (Canada)
- Advanced Accelerator Applications S.A. (France)
- IBA Molecular Imaging (Belgium)
What is the 10-year outlook for the global PET Radiopharmaceuticals market?
What factors are driving PET Radiopharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do PET Radiopharmaceuticals market opportunities vary by end market size?
How does PET Radiopharmaceuticals break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PET Radiopharmaceuticals Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for PET Radiopharmaceuticals by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for PET Radiopharmaceuticals by Country/Region, 2020, 2024 & 2031
2.2 PET Radiopharmaceuticals Segment by Type
2.2.1 F-18
2.2.2 Ru-82
2.2.3 Others
2.3 PET Radiopharmaceuticals Sales by Type
2.3.1 Global PET Radiopharmaceuticals Sales Market Share by Type (2020-2025)
2.3.2 Global PET Radiopharmaceuticals Revenue and Market Share by Type (2020-2025)
2.3.3 Global PET Radiopharmaceuticals Sale Price by Type (2020-2025)
2.4 PET Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Neurology
2.4.4 Others
2.5 PET Radiopharmaceuticals Sales by Application
2.5.1 Global PET Radiopharmaceuticals Sale Market Share by Application (2020-2025)
2.5.2 Global PET Radiopharmaceuticals Revenue and Market Share by Application (2020-2025)
2.5.3 Global PET Radiopharmaceuticals Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global PET Radiopharmaceuticals Breakdown Data by Company
3.1.1 Global PET Radiopharmaceuticals Annual Sales by Company (2020-2025)
3.1.2 Global PET Radiopharmaceuticals Sales Market Share by Company (2020-2025)
3.2 Global PET Radiopharmaceuticals Annual Revenue by Company (2020-2025)
3.2.1 Global PET Radiopharmaceuticals Revenue by Company (2020-2025)
3.2.2 Global PET Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
3.3 Global PET Radiopharmaceuticals Sale Price by Company
3.4 Key Manufacturers PET Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PET Radiopharmaceuticals Product Location Distribution
3.4.2 Players PET Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PET RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
4.1 World Historic PET Radiopharmaceuticals Market Size by Geographic Region (2020-2025)
4.1.1 Global PET Radiopharmaceuticals Annual Sales by Geographic Region (2020-2025)
4.1.2 Global PET Radiopharmaceuticals Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic PET Radiopharmaceuticals Market Size by Country/Region (2020-2025)
4.2.1 Global PET Radiopharmaceuticals Annual Sales by Country/Region (2020-2025)
4.2.2 Global PET Radiopharmaceuticals Annual Revenue by Country/Region (2020-2025)
4.3 Americas PET Radiopharmaceuticals Sales Growth
4.4 APAC PET Radiopharmaceuticals Sales Growth
4.5 Europe PET Radiopharmaceuticals Sales Growth
4.6 Middle East & Africa PET Radiopharmaceuticals Sales Growth
5 AMERICAS
5.1 Americas PET Radiopharmaceuticals Sales by Country
5.1.1 Americas PET Radiopharmaceuticals Sales by Country (2020-2025)
5.1.2 Americas PET Radiopharmaceuticals Revenue by Country (2020-2025)
5.2 Americas PET Radiopharmaceuticals Sales by Type (2020-2025)
5.3 Americas PET Radiopharmaceuticals Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PET Radiopharmaceuticals Sales by Region
6.1.1 APAC PET Radiopharmaceuticals Sales by Region (2020-2025)
6.1.2 APAC PET Radiopharmaceuticals Revenue by Region (2020-2025)
6.2 APAC PET Radiopharmaceuticals Sales by Type (2020-2025)
6.3 APAC PET Radiopharmaceuticals Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PET Radiopharmaceuticals by Country
7.1.1 Europe PET Radiopharmaceuticals Sales by Country (2020-2025)
7.1.2 Europe PET Radiopharmaceuticals Revenue by Country (2020-2025)
7.2 Europe PET Radiopharmaceuticals Sales by Type (2020-2025)
7.3 Europe PET Radiopharmaceuticals Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PET Radiopharmaceuticals by Country
8.1.1 Middle East & Africa PET Radiopharmaceuticals Sales by Country (2020-2025)
8.1.2 Middle East & Africa PET Radiopharmaceuticals Revenue by Country (2020-2025)
8.2 Middle East & Africa PET Radiopharmaceuticals Sales by Type (2020-2025)
8.3 Middle East & Africa PET Radiopharmaceuticals Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals
10.3 Manufacturing Process Analysis of PET Radiopharmaceuticals
10.4 Industry Chain Structure of PET Radiopharmaceuticals
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PET Radiopharmaceuticals Distributors
11.3 PET Radiopharmaceuticals Customer
12 WORLD FORECAST REVIEW FOR PET RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
12.1 Global PET Radiopharmaceuticals Market Size Forecast by Region
12.1.1 Global PET Radiopharmaceuticals Forecast by Region (2026-2031)
12.1.2 Global PET Radiopharmaceuticals Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global PET Radiopharmaceuticals Forecast by Type (2026-2031)
12.7 Global PET Radiopharmaceuticals Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Cardinal Health Inc. (U.S.)
13.1.1 Cardinal Health Inc. (U.S.) Company Information
13.1.2 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Portfolios and Specifications
13.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Cardinal Health Inc. (U.S.) Main Business Overview
13.1.5 Cardinal Health Inc. (U.S.) Latest Developments
13.2 Mallinckrodt plc (Ireland)
13.2.1 Mallinckrodt plc (Ireland) Company Information
13.2.2 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Portfolios and Specifications
13.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mallinckrodt plc (Ireland) Main Business Overview
13.2.5 Mallinckrodt plc (Ireland) Latest Developments
13.3 GE Healthcare (U.K.)
13.3.1 GE Healthcare (U.K.) Company Information
13.3.2 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Portfolios and Specifications
13.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GE Healthcare (U.K.) Main Business Overview
13.3.5 GE Healthcare (U.K.) Latest Developments
13.4 Lantheus Medical Imaging, Inc. (U.S.)
13.4.1 Lantheus Medical Imaging, Inc. (U.S.) Company Information
13.4.2 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Portfolios and Specifications
13.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Lantheus Medical Imaging, Inc. (U.S.) Main Business Overview
13.4.5 Lantheus Medical Imaging, Inc. (U.S.) Latest Developments
13.5 Bayer AG (Germany)
13.5.1 Bayer AG (Germany) Company Information
13.5.2 Bayer AG (Germany) PET Radiopharmaceuticals Product Portfolios and Specifications
13.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bayer AG (Germany) Main Business Overview
13.5.5 Bayer AG (Germany) Latest Developments
13.6 Bracco Imaging S.p.A (Italy)
13.6.1 Bracco Imaging S.p.A (Italy) Company Information
13.6.2 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Portfolios and Specifications
13.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Bracco Imaging S.p.A (Italy) Main Business Overview
13.6.5 Bracco Imaging S.p.A (Italy) Latest Developments
13.7 Eczacibasi-Monrol Nuclear Products (Turkey)
13.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Information
13.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Portfolios and Specifications
13.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) Main Business Overview
13.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Latest Developments
13.8 Nordion, Inc. (Canada)
13.8.1 Nordion, Inc. (Canada) Company Information
13.8.2 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Portfolios and Specifications
13.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Nordion, Inc. (Canada) Main Business Overview
13.8.5 Nordion, Inc. (Canada) Latest Developments
13.9 Advanced Accelerator Applications S.A. (France)
13.9.1 Advanced Accelerator Applications S.A. (France) Company Information
13.9.2 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Portfolios and Specifications
13.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Advanced Accelerator Applications S.A. (France) Main Business Overview
13.9.5 Advanced Accelerator Applications S.A. (France) Latest Developments
13.10 IBA Molecular Imaging (Belgium)
13.10.1 IBA Molecular Imaging (Belgium) Company Information
13.10.2 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Portfolios and Specifications
13.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 IBA Molecular Imaging (Belgium) Main Business Overview
13.10.5 IBA Molecular Imaging (Belgium) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global PET Radiopharmaceuticals Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for PET Radiopharmaceuticals by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for PET Radiopharmaceuticals by Country/Region, 2020, 2024 & 2031
2.2 PET Radiopharmaceuticals Segment by Type
2.2.1 F-18
2.2.2 Ru-82
2.2.3 Others
2.3 PET Radiopharmaceuticals Sales by Type
2.3.1 Global PET Radiopharmaceuticals Sales Market Share by Type (2020-2025)
2.3.2 Global PET Radiopharmaceuticals Revenue and Market Share by Type (2020-2025)
2.3.3 Global PET Radiopharmaceuticals Sale Price by Type (2020-2025)
2.4 PET Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Neurology
2.4.4 Others
2.5 PET Radiopharmaceuticals Sales by Application
2.5.1 Global PET Radiopharmaceuticals Sale Market Share by Application (2020-2025)
2.5.2 Global PET Radiopharmaceuticals Revenue and Market Share by Application (2020-2025)
2.5.3 Global PET Radiopharmaceuticals Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global PET Radiopharmaceuticals Breakdown Data by Company
3.1.1 Global PET Radiopharmaceuticals Annual Sales by Company (2020-2025)
3.1.2 Global PET Radiopharmaceuticals Sales Market Share by Company (2020-2025)
3.2 Global PET Radiopharmaceuticals Annual Revenue by Company (2020-2025)
3.2.1 Global PET Radiopharmaceuticals Revenue by Company (2020-2025)
3.2.2 Global PET Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
3.3 Global PET Radiopharmaceuticals Sale Price by Company
3.4 Key Manufacturers PET Radiopharmaceuticals Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers PET Radiopharmaceuticals Product Location Distribution
3.4.2 Players PET Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PET RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
4.1 World Historic PET Radiopharmaceuticals Market Size by Geographic Region (2020-2025)
4.1.1 Global PET Radiopharmaceuticals Annual Sales by Geographic Region (2020-2025)
4.1.2 Global PET Radiopharmaceuticals Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic PET Radiopharmaceuticals Market Size by Country/Region (2020-2025)
4.2.1 Global PET Radiopharmaceuticals Annual Sales by Country/Region (2020-2025)
4.2.2 Global PET Radiopharmaceuticals Annual Revenue by Country/Region (2020-2025)
4.3 Americas PET Radiopharmaceuticals Sales Growth
4.4 APAC PET Radiopharmaceuticals Sales Growth
4.5 Europe PET Radiopharmaceuticals Sales Growth
4.6 Middle East & Africa PET Radiopharmaceuticals Sales Growth
5 AMERICAS
5.1 Americas PET Radiopharmaceuticals Sales by Country
5.1.1 Americas PET Radiopharmaceuticals Sales by Country (2020-2025)
5.1.2 Americas PET Radiopharmaceuticals Revenue by Country (2020-2025)
5.2 Americas PET Radiopharmaceuticals Sales by Type (2020-2025)
5.3 Americas PET Radiopharmaceuticals Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC PET Radiopharmaceuticals Sales by Region
6.1.1 APAC PET Radiopharmaceuticals Sales by Region (2020-2025)
6.1.2 APAC PET Radiopharmaceuticals Revenue by Region (2020-2025)
6.2 APAC PET Radiopharmaceuticals Sales by Type (2020-2025)
6.3 APAC PET Radiopharmaceuticals Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe PET Radiopharmaceuticals by Country
7.1.1 Europe PET Radiopharmaceuticals Sales by Country (2020-2025)
7.1.2 Europe PET Radiopharmaceuticals Revenue by Country (2020-2025)
7.2 Europe PET Radiopharmaceuticals Sales by Type (2020-2025)
7.3 Europe PET Radiopharmaceuticals Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa PET Radiopharmaceuticals by Country
8.1.1 Middle East & Africa PET Radiopharmaceuticals Sales by Country (2020-2025)
8.1.2 Middle East & Africa PET Radiopharmaceuticals Revenue by Country (2020-2025)
8.2 Middle East & Africa PET Radiopharmaceuticals Sales by Type (2020-2025)
8.3 Middle East & Africa PET Radiopharmaceuticals Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals
10.3 Manufacturing Process Analysis of PET Radiopharmaceuticals
10.4 Industry Chain Structure of PET Radiopharmaceuticals
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 PET Radiopharmaceuticals Distributors
11.3 PET Radiopharmaceuticals Customer
12 WORLD FORECAST REVIEW FOR PET RADIOPHARMACEUTICALS BY GEOGRAPHIC REGION
12.1 Global PET Radiopharmaceuticals Market Size Forecast by Region
12.1.1 Global PET Radiopharmaceuticals Forecast by Region (2026-2031)
12.1.2 Global PET Radiopharmaceuticals Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global PET Radiopharmaceuticals Forecast by Type (2026-2031)
12.7 Global PET Radiopharmaceuticals Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Cardinal Health Inc. (U.S.)
13.1.1 Cardinal Health Inc. (U.S.) Company Information
13.1.2 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Portfolios and Specifications
13.1.3 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Cardinal Health Inc. (U.S.) Main Business Overview
13.1.5 Cardinal Health Inc. (U.S.) Latest Developments
13.2 Mallinckrodt plc (Ireland)
13.2.1 Mallinckrodt plc (Ireland) Company Information
13.2.2 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Portfolios and Specifications
13.2.3 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Mallinckrodt plc (Ireland) Main Business Overview
13.2.5 Mallinckrodt plc (Ireland) Latest Developments
13.3 GE Healthcare (U.K.)
13.3.1 GE Healthcare (U.K.) Company Information
13.3.2 GE Healthcare (U.K.) PET Radiopharmaceuticals Product Portfolios and Specifications
13.3.3 GE Healthcare (U.K.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 GE Healthcare (U.K.) Main Business Overview
13.3.5 GE Healthcare (U.K.) Latest Developments
13.4 Lantheus Medical Imaging, Inc. (U.S.)
13.4.1 Lantheus Medical Imaging, Inc. (U.S.) Company Information
13.4.2 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Portfolios and Specifications
13.4.3 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Lantheus Medical Imaging, Inc. (U.S.) Main Business Overview
13.4.5 Lantheus Medical Imaging, Inc. (U.S.) Latest Developments
13.5 Bayer AG (Germany)
13.5.1 Bayer AG (Germany) Company Information
13.5.2 Bayer AG (Germany) PET Radiopharmaceuticals Product Portfolios and Specifications
13.5.3 Bayer AG (Germany) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Bayer AG (Germany) Main Business Overview
13.5.5 Bayer AG (Germany) Latest Developments
13.6 Bracco Imaging S.p.A (Italy)
13.6.1 Bracco Imaging S.p.A (Italy) Company Information
13.6.2 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Portfolios and Specifications
13.6.3 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Bracco Imaging S.p.A (Italy) Main Business Overview
13.6.5 Bracco Imaging S.p.A (Italy) Latest Developments
13.7 Eczacibasi-Monrol Nuclear Products (Turkey)
13.7.1 Eczacibasi-Monrol Nuclear Products (Turkey) Company Information
13.7.2 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Portfolios and Specifications
13.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) Main Business Overview
13.7.5 Eczacibasi-Monrol Nuclear Products (Turkey) Latest Developments
13.8 Nordion, Inc. (Canada)
13.8.1 Nordion, Inc. (Canada) Company Information
13.8.2 Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Portfolios and Specifications
13.8.3 Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Nordion, Inc. (Canada) Main Business Overview
13.8.5 Nordion, Inc. (Canada) Latest Developments
13.9 Advanced Accelerator Applications S.A. (France)
13.9.1 Advanced Accelerator Applications S.A. (France) Company Information
13.9.2 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Portfolios and Specifications
13.9.3 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Advanced Accelerator Applications S.A. (France) Main Business Overview
13.9.5 Advanced Accelerator Applications S.A. (France) Latest Developments
13.10 IBA Molecular Imaging (Belgium)
13.10.1 IBA Molecular Imaging (Belgium) Company Information
13.10.2 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Portfolios and Specifications
13.10.3 IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 IBA Molecular Imaging (Belgium) Main Business Overview
13.10.5 IBA Molecular Imaging (Belgium) Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. PET Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. PET Radiopharmaceuticals Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of F-18
Table 4. Major Players of Ru-82
Table 5. Major Players of Others
Table 6. Global PET Radiopharmaceuticals Sales by Type (2020-2025) & (K Pcs)
Table 7. Global PET Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 8. Global PET Radiopharmaceuticals Revenue by Type (2020-2025) & ($ million)
Table 9. Global PET Radiopharmaceuticals Revenue Market Share by Type (2020-2025)
Table 10. Global PET Radiopharmaceuticals Sale Price by Type (2020-2025) & (USD/Pcs)
Table 11. Global PET Radiopharmaceuticals Sale by Application (2020-2025) & (K Pcs)
Table 12. Global PET Radiopharmaceuticals Sale Market Share by Application (2020-2025)
Table 13. Global PET Radiopharmaceuticals Revenue by Application (2020-2025) & ($ million)
Table 14. Global PET Radiopharmaceuticals Revenue Market Share by Application (2020-2025)
Table 15. Global PET Radiopharmaceuticals Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global PET Radiopharmaceuticals Sales by Company (2020-2025) & (K Pcs)
Table 17. Global PET Radiopharmaceuticals Sales Market Share by Company (2020-2025)
Table 18. Global PET Radiopharmaceuticals Revenue by Company (2020-2025) & ($ millions)
Table 19. Global PET Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
Table 20. Global PET Radiopharmaceuticals Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers PET Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 22. Players PET Radiopharmaceuticals Products Offered
Table 23. PET Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global PET Radiopharmaceuticals Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global PET Radiopharmaceuticals Sales Market Share Geographic Region (2020-2025)
Table 28. Global PET Radiopharmaceuticals Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global PET Radiopharmaceuticals Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global PET Radiopharmaceuticals Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global PET Radiopharmaceuticals Sales Market Share by Country/Region (2020-2025)
Table 32. Global PET Radiopharmaceuticals Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global PET Radiopharmaceuticals Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas PET Radiopharmaceuticals Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas PET Radiopharmaceuticals Sales Market Share by Country (2020-2025)
Table 36. Americas PET Radiopharmaceuticals Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas PET Radiopharmaceuticals Sales by Type (2020-2025) & (K Pcs)
Table 38. Americas PET Radiopharmaceuticals Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC PET Radiopharmaceuticals Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC PET Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 41. APAC PET Radiopharmaceuticals Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC PET Radiopharmaceuticals Sales by Type (2020-2025) & (K Pcs)
Table 43. APAC PET Radiopharmaceuticals Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe PET Radiopharmaceuticals Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe PET Radiopharmaceuticals Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe PET Radiopharmaceuticals Sales by Type (2020-2025) & (K Pcs)
Table 47. Europe PET Radiopharmaceuticals Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa PET Radiopharmaceuticals Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa PET Radiopharmaceuticals Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa PET Radiopharmaceuticals Sales by Type (2020-2025) & (K Pcs)
Table 51. Middle East & Africa PET Radiopharmaceuticals Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of PET Radiopharmaceuticals
Table 53. Key Market Challenges & Risks of PET Radiopharmaceuticals
Table 54. Key Industry Trends of PET Radiopharmaceuticals
Table 55. PET Radiopharmaceuticals Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. PET Radiopharmaceuticals Distributors List
Table 58. PET Radiopharmaceuticals Customer List
Table 59. Global PET Radiopharmaceuticals Sales Forecast by Region (2026-2031) & (K Pcs)
Table 60. Global PET Radiopharmaceuticals Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas PET Radiopharmaceuticals Sales Forecast by Country (2026-2031) & (K Pcs)
Table 62. Americas PET Radiopharmaceuticals Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC PET Radiopharmaceuticals Sales Forecast by Region (2026-2031) & (K Pcs)
Table 64. APAC PET Radiopharmaceuticals Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe PET Radiopharmaceuticals Sales Forecast by Country (2026-2031) & (K Pcs)
Table 66. Europe PET Radiopharmaceuticals Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa PET Radiopharmaceuticals Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa PET Radiopharmaceuticals Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global PET Radiopharmaceuticals Sales Forecast by Type (2026-2031) & (K Pcs)
Table 70. Global PET Radiopharmaceuticals Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global PET Radiopharmaceuticals Sales Forecast by Application (2026-2031) & (K Pcs)
Table 72. Global PET Radiopharmaceuticals Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Cardinal Health Inc. (U.S.) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 74. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 75. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. Cardinal Health Inc. (U.S.) Main Business
Table 77. Cardinal Health Inc. (U.S.) Latest Developments
Table 78. Mallinckrodt plc (Ireland) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 79. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 80. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. Mallinckrodt plc (Ireland) Main Business
Table 82. Mallinckrodt plc (Ireland) Latest Developments
Table 83. GE Healthcare (U.K.) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 84. GE Healthcare (U.K.) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 85. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 86. GE Healthcare (U.K.) Main Business
Table 87. GE Healthcare (U.K.) Latest Developments
Table 88. Lantheus Medical Imaging, Inc. (U.S.) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 89. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 90. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 91. Lantheus Medical Imaging, Inc. (U.S.) Main Business
Table 92. Lantheus Medical Imaging, Inc. (U.S.) Latest Developments
Table 93. Bayer AG (Germany) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 94. Bayer AG (Germany) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 95. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 96. Bayer AG (Germany) Main Business
Table 97. Bayer AG (Germany) Latest Developments
Table 98. Bracco Imaging S.p.A (Italy) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 99. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 100. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 101. Bracco Imaging S.p.A (Italy) Main Business
Table 102. Bracco Imaging S.p.A (Italy) Latest Developments
Table 103. Eczacibasi-Monrol Nuclear Products (Turkey) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 104. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 105. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 106. Eczacibasi-Monrol Nuclear Products (Turkey) Main Business
Table 107. Eczacibasi-Monrol Nuclear Products (Turkey) Latest Developments
Table 108. Nordion, Inc. (Canada) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 109. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 110. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 111. Nordion, Inc. (Canada) Main Business
Table 112. Nordion, Inc. (Canada) Latest Developments
Table 113. Advanced Accelerator Applications S.A. (France) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 114. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 115. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 116. Advanced Accelerator Applications S.A. (France) Main Business
Table 117. Advanced Accelerator Applications S.A. (France) Latest Developments
Table 118. IBA Molecular Imaging (Belgium) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 119. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 120. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 121. IBA Molecular Imaging (Belgium) Main Business
Table 122. IBA Molecular Imaging (Belgium) Latest Developments
Table 1. PET Radiopharmaceuticals Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. PET Radiopharmaceuticals Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of F-18
Table 4. Major Players of Ru-82
Table 5. Major Players of Others
Table 6. Global PET Radiopharmaceuticals Sales by Type (2020-2025) & (K Pcs)
Table 7. Global PET Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Table 8. Global PET Radiopharmaceuticals Revenue by Type (2020-2025) & ($ million)
Table 9. Global PET Radiopharmaceuticals Revenue Market Share by Type (2020-2025)
Table 10. Global PET Radiopharmaceuticals Sale Price by Type (2020-2025) & (USD/Pcs)
Table 11. Global PET Radiopharmaceuticals Sale by Application (2020-2025) & (K Pcs)
Table 12. Global PET Radiopharmaceuticals Sale Market Share by Application (2020-2025)
Table 13. Global PET Radiopharmaceuticals Revenue by Application (2020-2025) & ($ million)
Table 14. Global PET Radiopharmaceuticals Revenue Market Share by Application (2020-2025)
Table 15. Global PET Radiopharmaceuticals Sale Price by Application (2020-2025) & (USD/Pcs)
Table 16. Global PET Radiopharmaceuticals Sales by Company (2020-2025) & (K Pcs)
Table 17. Global PET Radiopharmaceuticals Sales Market Share by Company (2020-2025)
Table 18. Global PET Radiopharmaceuticals Revenue by Company (2020-2025) & ($ millions)
Table 19. Global PET Radiopharmaceuticals Revenue Market Share by Company (2020-2025)
Table 20. Global PET Radiopharmaceuticals Sale Price by Company (2020-2025) & (USD/Pcs)
Table 21. Key Manufacturers PET Radiopharmaceuticals Producing Area Distribution and Sales Area
Table 22. Players PET Radiopharmaceuticals Products Offered
Table 23. PET Radiopharmaceuticals Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global PET Radiopharmaceuticals Sales by Geographic Region (2020-2025) & (K Pcs)
Table 27. Global PET Radiopharmaceuticals Sales Market Share Geographic Region (2020-2025)
Table 28. Global PET Radiopharmaceuticals Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global PET Radiopharmaceuticals Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global PET Radiopharmaceuticals Sales by Country/Region (2020-2025) & (K Pcs)
Table 31. Global PET Radiopharmaceuticals Sales Market Share by Country/Region (2020-2025)
Table 32. Global PET Radiopharmaceuticals Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global PET Radiopharmaceuticals Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas PET Radiopharmaceuticals Sales by Country (2020-2025) & (K Pcs)
Table 35. Americas PET Radiopharmaceuticals Sales Market Share by Country (2020-2025)
Table 36. Americas PET Radiopharmaceuticals Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas PET Radiopharmaceuticals Sales by Type (2020-2025) & (K Pcs)
Table 38. Americas PET Radiopharmaceuticals Sales by Application (2020-2025) & (K Pcs)
Table 39. APAC PET Radiopharmaceuticals Sales by Region (2020-2025) & (K Pcs)
Table 40. APAC PET Radiopharmaceuticals Sales Market Share by Region (2020-2025)
Table 41. APAC PET Radiopharmaceuticals Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC PET Radiopharmaceuticals Sales by Type (2020-2025) & (K Pcs)
Table 43. APAC PET Radiopharmaceuticals Sales by Application (2020-2025) & (K Pcs)
Table 44. Europe PET Radiopharmaceuticals Sales by Country (2020-2025) & (K Pcs)
Table 45. Europe PET Radiopharmaceuticals Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe PET Radiopharmaceuticals Sales by Type (2020-2025) & (K Pcs)
Table 47. Europe PET Radiopharmaceuticals Sales by Application (2020-2025) & (K Pcs)
Table 48. Middle East & Africa PET Radiopharmaceuticals Sales by Country (2020-2025) & (K Pcs)
Table 49. Middle East & Africa PET Radiopharmaceuticals Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa PET Radiopharmaceuticals Sales by Type (2020-2025) & (K Pcs)
Table 51. Middle East & Africa PET Radiopharmaceuticals Sales by Application (2020-2025) & (K Pcs)
Table 52. Key Market Drivers & Growth Opportunities of PET Radiopharmaceuticals
Table 53. Key Market Challenges & Risks of PET Radiopharmaceuticals
Table 54. Key Industry Trends of PET Radiopharmaceuticals
Table 55. PET Radiopharmaceuticals Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. PET Radiopharmaceuticals Distributors List
Table 58. PET Radiopharmaceuticals Customer List
Table 59. Global PET Radiopharmaceuticals Sales Forecast by Region (2026-2031) & (K Pcs)
Table 60. Global PET Radiopharmaceuticals Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas PET Radiopharmaceuticals Sales Forecast by Country (2026-2031) & (K Pcs)
Table 62. Americas PET Radiopharmaceuticals Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC PET Radiopharmaceuticals Sales Forecast by Region (2026-2031) & (K Pcs)
Table 64. APAC PET Radiopharmaceuticals Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe PET Radiopharmaceuticals Sales Forecast by Country (2026-2031) & (K Pcs)
Table 66. Europe PET Radiopharmaceuticals Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa PET Radiopharmaceuticals Sales Forecast by Country (2026-2031) & (K Pcs)
Table 68. Middle East & Africa PET Radiopharmaceuticals Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global PET Radiopharmaceuticals Sales Forecast by Type (2026-2031) & (K Pcs)
Table 70. Global PET Radiopharmaceuticals Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global PET Radiopharmaceuticals Sales Forecast by Application (2026-2031) & (K Pcs)
Table 72. Global PET Radiopharmaceuticals Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Cardinal Health Inc. (U.S.) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 74. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 75. Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 76. Cardinal Health Inc. (U.S.) Main Business
Table 77. Cardinal Health Inc. (U.S.) Latest Developments
Table 78. Mallinckrodt plc (Ireland) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 79. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 80. Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. Mallinckrodt plc (Ireland) Main Business
Table 82. Mallinckrodt plc (Ireland) Latest Developments
Table 83. GE Healthcare (U.K.) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 84. GE Healthcare (U.K.) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 85. GE Healthcare (U.K.) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 86. GE Healthcare (U.K.) Main Business
Table 87. GE Healthcare (U.K.) Latest Developments
Table 88. Lantheus Medical Imaging, Inc. (U.S.) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 89. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 90. Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 91. Lantheus Medical Imaging, Inc. (U.S.) Main Business
Table 92. Lantheus Medical Imaging, Inc. (U.S.) Latest Developments
Table 93. Bayer AG (Germany) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 94. Bayer AG (Germany) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 95. Bayer AG (Germany) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 96. Bayer AG (Germany) Main Business
Table 97. Bayer AG (Germany) Latest Developments
Table 98. Bracco Imaging S.p.A (Italy) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 99. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 100. Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 101. Bracco Imaging S.p.A (Italy) Main Business
Table 102. Bracco Imaging S.p.A (Italy) Latest Developments
Table 103. Eczacibasi-Monrol Nuclear Products (Turkey) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 104. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 105. Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 106. Eczacibasi-Monrol Nuclear Products (Turkey) Main Business
Table 107. Eczacibasi-Monrol Nuclear Products (Turkey) Latest Developments
Table 108. Nordion, Inc. (Canada) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 109. Nordion, Inc. (Canada) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 110. Nordion, Inc. (Canada) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 111. Nordion, Inc. (Canada) Main Business
Table 112. Nordion, Inc. (Canada) Latest Developments
Table 113. Advanced Accelerator Applications S.A. (France) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 114. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 115. Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 116. Advanced Accelerator Applications S.A. (France) Main Business
Table 117. Advanced Accelerator Applications S.A. (France) Latest Developments
Table 118. IBA Molecular Imaging (Belgium) Basic Information, PET Radiopharmaceuticals Manufacturing Base, Sales Area and Its Competitors
Table 119. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Product Portfolios and Specifications
Table 120. IBA Molecular Imaging (Belgium) PET Radiopharmaceuticals Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 121. IBA Molecular Imaging (Belgium) Main Business
Table 122. IBA Molecular Imaging (Belgium) Latest Developments
LIST OF FIGURES
Figure 1. Picture of PET Radiopharmaceuticals
Figure 2. PET Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PET Radiopharmaceuticals Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global PET Radiopharmaceuticals Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. PET Radiopharmaceuticals Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. PET Radiopharmaceuticals Sales Market Share by Country/Region (2024)
Figure 10. PET Radiopharmaceuticals Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of F-18
Figure 12. Product Picture of Ru-82
Figure 13. Product Picture of Others
Figure 14. Global PET Radiopharmaceuticals Sales Market Share by Type in 2025
Figure 15. Global PET Radiopharmaceuticals Revenue Market Share by Type (2020-2025)
Figure 16. PET Radiopharmaceuticals Consumed in Oncology
Figure 17. Global PET Radiopharmaceuticals Market: Oncology (2020-2025) & (K Pcs)
Figure 18. PET Radiopharmaceuticals Consumed in Cardiology
Figure 19. Global PET Radiopharmaceuticals Market: Cardiology (2020-2025) & (K Pcs)
Figure 20. PET Radiopharmaceuticals Consumed in Neurology
Figure 21. Global PET Radiopharmaceuticals Market: Neurology (2020-2025) & (K Pcs)
Figure 22. PET Radiopharmaceuticals Consumed in Others
Figure 23. Global PET Radiopharmaceuticals Market: Others (2020-2025) & (K Pcs)
Figure 24. Global PET Radiopharmaceuticals Sale Market Share by Application (2024)
Figure 25. Global PET Radiopharmaceuticals Revenue Market Share by Application in 2025
Figure 26. PET Radiopharmaceuticals Sales by Company in 2025 (K Pcs)
Figure 27. Global PET Radiopharmaceuticals Sales Market Share by Company in 2025
Figure 28. PET Radiopharmaceuticals Revenue by Company in 2025 ($ millions)
Figure 29. Global PET Radiopharmaceuticals Revenue Market Share by Company in 2025
Figure 30. Global PET Radiopharmaceuticals Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global PET Radiopharmaceuticals Revenue Market Share by Geographic Region in 2025
Figure 32. Americas PET Radiopharmaceuticals Sales 2020-2025 (K Pcs)
Figure 33. Americas PET Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 34. APAC PET Radiopharmaceuticals Sales 2020-2025 (K Pcs)
Figure 35. APAC PET Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 36. Europe PET Radiopharmaceuticals Sales 2020-2025 (K Pcs)
Figure 37. Europe PET Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa PET Radiopharmaceuticals Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa PET Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 40. Americas PET Radiopharmaceuticals Sales Market Share by Country in 2025
Figure 41. Americas PET Radiopharmaceuticals Revenue Market Share by Country (2020-2025)
Figure 42. Americas PET Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Figure 43. Americas PET Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 44. United States PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC PET Radiopharmaceuticals Sales Market Share by Region in 2025
Figure 49. APAC PET Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Figure 50. APAC PET Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Figure 51. APAC PET Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 52. China PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 56. India PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe PET Radiopharmaceuticals Sales Market Share by Country in 2025
Figure 60. Europe PET Radiopharmaceuticals Revenue Market Share by Country (2020-2025)
Figure 61. Europe PET Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Figure 62. Europe PET Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 63. Germany PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 64. France PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 65. UK PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 71. Egypt PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals in 2025
Figure 77. Manufacturing Process Analysis of PET Radiopharmaceuticals
Figure 78. Industry Chain Structure of PET Radiopharmaceuticals
Figure 79. Channels of Distribution
Figure 80. Global PET Radiopharmaceuticals Sales Market Forecast by Region (2026-2031)
Figure 81. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global PET Radiopharmaceuticals Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global PET Radiopharmaceuticals Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of PET Radiopharmaceuticals
Figure 2. PET Radiopharmaceuticals Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global PET Radiopharmaceuticals Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global PET Radiopharmaceuticals Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. PET Radiopharmaceuticals Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. PET Radiopharmaceuticals Sales Market Share by Country/Region (2024)
Figure 10. PET Radiopharmaceuticals Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of F-18
Figure 12. Product Picture of Ru-82
Figure 13. Product Picture of Others
Figure 14. Global PET Radiopharmaceuticals Sales Market Share by Type in 2025
Figure 15. Global PET Radiopharmaceuticals Revenue Market Share by Type (2020-2025)
Figure 16. PET Radiopharmaceuticals Consumed in Oncology
Figure 17. Global PET Radiopharmaceuticals Market: Oncology (2020-2025) & (K Pcs)
Figure 18. PET Radiopharmaceuticals Consumed in Cardiology
Figure 19. Global PET Radiopharmaceuticals Market: Cardiology (2020-2025) & (K Pcs)
Figure 20. PET Radiopharmaceuticals Consumed in Neurology
Figure 21. Global PET Radiopharmaceuticals Market: Neurology (2020-2025) & (K Pcs)
Figure 22. PET Radiopharmaceuticals Consumed in Others
Figure 23. Global PET Radiopharmaceuticals Market: Others (2020-2025) & (K Pcs)
Figure 24. Global PET Radiopharmaceuticals Sale Market Share by Application (2024)
Figure 25. Global PET Radiopharmaceuticals Revenue Market Share by Application in 2025
Figure 26. PET Radiopharmaceuticals Sales by Company in 2025 (K Pcs)
Figure 27. Global PET Radiopharmaceuticals Sales Market Share by Company in 2025
Figure 28. PET Radiopharmaceuticals Revenue by Company in 2025 ($ millions)
Figure 29. Global PET Radiopharmaceuticals Revenue Market Share by Company in 2025
Figure 30. Global PET Radiopharmaceuticals Sales Market Share by Geographic Region (2020-2025)
Figure 31. Global PET Radiopharmaceuticals Revenue Market Share by Geographic Region in 2025
Figure 32. Americas PET Radiopharmaceuticals Sales 2020-2025 (K Pcs)
Figure 33. Americas PET Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 34. APAC PET Radiopharmaceuticals Sales 2020-2025 (K Pcs)
Figure 35. APAC PET Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 36. Europe PET Radiopharmaceuticals Sales 2020-2025 (K Pcs)
Figure 37. Europe PET Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 38. Middle East & Africa PET Radiopharmaceuticals Sales 2020-2025 (K Pcs)
Figure 39. Middle East & Africa PET Radiopharmaceuticals Revenue 2020-2025 ($ millions)
Figure 40. Americas PET Radiopharmaceuticals Sales Market Share by Country in 2025
Figure 41. Americas PET Radiopharmaceuticals Revenue Market Share by Country (2020-2025)
Figure 42. Americas PET Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Figure 43. Americas PET Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 44. United States PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 45. Canada PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 46. Mexico PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 47. Brazil PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 48. APAC PET Radiopharmaceuticals Sales Market Share by Region in 2025
Figure 49. APAC PET Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
Figure 50. APAC PET Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Figure 51. APAC PET Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 52. China PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 53. Japan PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 54. South Korea PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 55. Southeast Asia PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 56. India PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 57. Australia PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 58. China Taiwan PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 59. Europe PET Radiopharmaceuticals Sales Market Share by Country in 2025
Figure 60. Europe PET Radiopharmaceuticals Revenue Market Share by Country (2020-2025)
Figure 61. Europe PET Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Figure 62. Europe PET Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 63. Germany PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 64. France PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 65. UK PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 66. Italy PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 67. Russia PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 68. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Country (2020-2025)
Figure 69. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Type (2020-2025)
Figure 70. Middle East & Africa PET Radiopharmaceuticals Sales Market Share by Application (2020-2025)
Figure 71. Egypt PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 72. South Africa PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 73. Israel PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 74. Turkey PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 75. GCC Countries PET Radiopharmaceuticals Revenue Growth 2020-2025 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals in 2025
Figure 77. Manufacturing Process Analysis of PET Radiopharmaceuticals
Figure 78. Industry Chain Structure of PET Radiopharmaceuticals
Figure 79. Channels of Distribution
Figure 80. Global PET Radiopharmaceuticals Sales Market Forecast by Region (2026-2031)
Figure 81. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Region (2026-2031)
Figure 82. Global PET Radiopharmaceuticals Sales Market Share Forecast by Type (2026-2031)
Figure 83. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Type (2026-2031)
Figure 84. Global PET Radiopharmaceuticals Sales Market Share Forecast by Application (2026-2031)
Figure 85. Global PET Radiopharmaceuticals Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Fibrocystic Breasts Diagnostics and Treatment Market Growth (Status and Outlook) 2024-2030
US$ 3,660.00
December 2024
94 pages
Global Robotic Prosthesis Market Growth 2023-2029
US$ 3,660.00
March 2023
116 pages
Global Animal Insulin Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
80 pages
Global Gynecology Digital Stethoscope Market Growth 2023-2029
US$ 3,660.00
March 2023
103 pages
Global B220 Antibody Market Growth 2023-2029
US$ 3,660.00
March 2023
115 pages
